Jeff Schaffnit: Honoring Excellence in Rare Blood Disorder Education and Storytelling
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“I’m proud to share that two Sanofi Rare Blood Disorders initiatives have been named finalists in this year’s Fierce Pharma Marketing Awards!
In the Innovation Challenge Category, ‘Sanofi ITP Know What Counts’, developed with Pivot Design, has earned finalist recognition for its patient-centered approach to education and engagement.
‘Dismissed’, the powerful documentary created in partnership Believe Limited, is also a finalist in the Online Video or Film category, recognized for its authentic storytelling that brings to life experience of being a woman with hemophilia.
These nominations reflect the dedication of our teams and partners, who are committed to creating meaningful work that benefits the rare blood disorders community every day.
Congratulations to everyone involved!”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics